164 related articles for article (PubMed ID: 20657180)
21. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
22. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma.
el-Naggar AK; Lee MS; Wang G; Luna MA; Goepfert H; Batsakis JG
Cancer; 1993 Aug; 72(3):881-6. PubMed ID: 8101470
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
24. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
25. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.
Hewitt C; Wilson P; McGlinn E; MacFarlane G; Papageorgiou A; Woodwards RT; Sloan P; Gollin SM; Paterson I; Parkinson KK; Read AP; Thakker N
Cancer Lett; 2004 Jun; 209(2):207-13. PubMed ID: 15159023
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas.
Pehlivan D; Gunduz E; Gunduz M; Nagatsuka H; Beder LB; Cengiz B; Rivera RS; Fukushima K; Palanduz S; Ozturk S; Yamanaka N; Shimizu K
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1267-76. PubMed ID: 18521630
[TBL] [Abstract][Full Text] [Related]
27. Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique.
Tan D; Wiseman S; Zhou Y; Li Q; Ward P; Slocum HK; Alrawi S; Loree T; Hicks W; Rigual N; Anderson G; Stoler D
Diagn Mol Pathol; 2004 Mar; 13(1):33-40. PubMed ID: 15163007
[TBL] [Abstract][Full Text] [Related]
28. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
29. The role of genetic susceptibility in head and neck squamous cell carcinoma.
Abou-Elhamd KE; Habib TN; Moussa AE; Badawy BS
Eur Arch Otorhinolaryngol; 2008 Feb; 265(2):217-22. PubMed ID: 17917736
[TBL] [Abstract][Full Text] [Related]
30. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
31. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss.
Latif F; Fivash M; Glenn G; Tory K; Orcutt ML; Hampsch K; Delisio J; Lerman M; Cowan J; Beckett M
Cancer Res; 1992 Mar; 52(6):1451-6. PubMed ID: 1540952
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.
Coon SW; Savera AT; Zarbo RJ; Benninger MS; Chase GA; Rybicki BA; Van Dyke DL
Int J Cancer; 2004 Aug; 111(2):206-12. PubMed ID: 15197772
[TBL] [Abstract][Full Text] [Related]
34. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers.
Rowley H; Jones A; Spandidos D; Field J
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):497-501. PubMed ID: 8615966
[TBL] [Abstract][Full Text] [Related]
35. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
[TBL] [Abstract][Full Text] [Related]
37. The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.
Oh JJ; Koegel AK; Phan DT; Razfar A; Slamon DJ
Lung Cancer; 2007 Oct; 58(1):7-14. PubMed ID: 17606309
[TBL] [Abstract][Full Text] [Related]
38. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
[TBL] [Abstract][Full Text] [Related]
39. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
Mao L; Fan YH; Lotan R; Hong WK
Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
[TBL] [Abstract][Full Text] [Related]
40. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
